For patients on GLP-1 medications, AI can flag elevated risks for specific complications, prompting clinicians to adjust therapy or order targeted tests before symptoms appear
Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
The synergy is real but not transformative
If you want a plan and a coach (not guesswork), start with our $99 three-week trial
With its unique formulation and advanced technology, Tirzepatide offers a revolutionary approach to managing type 2 diabetes and obesity-related comorbidities
